This activity dives into pressing questions regarding IgE-mediated food allergies, including current treatment approaches, methods for evaluating treatment response, strategies for communicating goals of care, and considerations for identifying appropriate candidates for therapy. It also explores practical approaches to improving access to care for underserved populations. The discussion is enlivened with narrative commentary from a patient and a caregiver on their experience with IgE-mediated food allergy and its treatment.
Upon completion of this activity, participants should be better able to:
Associate Professor, University of North Carolina School of Medicine
Chief, Division of Pediatric Allergy and Immunology
Director, UNC Food Allergy Initiative
Chapel Hill, NC
Caregiver of a patient for this educational activity
Patient for this educational activity
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Edwin H. Kim, MD, MS, faculty for this educational activity, has the following relevant financial relationships:
ALK, Allergy Therapeutics Ltd., Belhaven BioPharma, Cellergy Pharma, Genentech, GrowHappy, Hanimune Therapeutics, IgGenix, Inimmune, Kenota Health, Phylaxis Bioscience, Ukko (Consultant).
Stephen Schworer has no relevant financial relationships.
Yamini Virkud has no relevant financial relationships.
Jointly Provided by Partners for Advancing Clinical Education and RMEI Medical Education, LLC.
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and RMEI Medical Education, LLC. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Partners designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 contact hour(s).
Continuing Pharmacy Education
Partners designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008073-9999-26-072-H01-P)
Type of Activity: Knowledge
For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
Participation in this self-study activity should be completed in approximately 0.75 hour(s). To successfully complete this activity and receive CE credit, learners must follow these steps during the period from April 30, 2026 through April 29, 2027:
You must receive a test score of at least 75% and respond to all evaluation questions to receive a certificate.
For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the online evaluation, your credit will be submitted to CPE Monitor. Please check your NABP account within thirty (30) days to make sure the credit has posted.
Contact This Provider: [email protected]
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
